相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
RT
- 保质期:
见标签
- 库存:
999
- 供应商:
鹿森生物
- CAS号:
59247-13-1
- 规格:
5mg
一般描述
Gangliosides are major constituents of neuronal cell membranes and endoplasmic reticulum. They contain a sialated polysaccharide chain linked to ceramide through a β-glycosidic linkage. For classification of gangliosides see Svennerholm, L., et al. (eds.), Structure and Function of Gangliosides, New York, Plenum, 1980.
应用
Trisialoganglioside-GT1b from bovine brain has been used:
in high performance thin layer chromatography (HPTLC)[1]
in membrane GM1 assays[2]
as reference standards for TLC (thin layer chromatography) and as antigens for ELISA (enzyme-linked immunosorbent assay)[3]
生化/生理作用
Ganglioside marker for metastatic brain tumors. Modulates cellular differentiation; prevents glutamate neurotoxicity; inhibits mitogenesis stimulated by lectins such as Con A. Converted to GD1b by bacterial and mammalian sialidases.
分析说明
Homogeneous aqueous preparations can be obtained by suspending the compound in water, buffer or cell culture medium and sonicating briefly to facilitate the micelle formation.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验PNAS:RAS 抑制剂又添一员,新型蛋白模拟物或为癌症治疗
-5 结合到了 Ras 的 Sos 结合位点。图片来源:PNASRas 突变调控细胞对 Sos 蛋白模拟物的摄取和作用Sos 蛋白模拟物对细胞发挥调节作用需要进入细胞内部。活细胞荧光显微镜和流式细胞术显示,Ras 突变的膀胱和肺癌细胞中,细胞显著摄取荧光素标记的 CHDSos-5 进入胞浆。Ras 突变的癌细胞对 CHDSos-5 的摄取增强表明 Sos 蛋白类似物可能对这些细胞有选择性的毒性。基于这一前提,研究团队探索了 CHDSos-5 与 H-Ras 突变型结合的可能性。野生型和 G
。加入甘氨酸可以消除甲醛使交联反应终止。1.1.准备两个长满细胞的150cm2的细胞培养皿(1*107-5*107 个细胞/皿)。将甲醛直接滴入PBS洗过的细胞培养皿中,使其终浓度为0.75%,然后在室温缓慢旋转10分钟,使蛋白和DNA发生交联。1.2 加入甘氨酸使其终浓度为125mM,在室温晃动孵育5分钟。1.3 使用10ml预冷PBS清洗细胞2次1.4 使用细胞刮将细胞收获放入 5ml 预冷PBS中,并转入50ml的管子。1.5.在皿里加入3mlPBS,将剩余的细胞转移到50ml管子里1000g
by adding 1µl Rnase A (10mg/ml) and 20µl of 5M NaCl. Incubate the samples in a 65° water bath or heat block for 4-5 hours to overnight (note 5); ;After the reverse cross-linking the elutes are treated with 10µl of 0.5M EDTA, 20µl of 1M Tris-HCL, pH
技术资料暂无技术资料 索取技术资料






